<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>451-RESERPINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="RESERPINE" rxcui="9260">
<ATC code="C02AA02" />
<ATC code="C02LA01" />
<ATC code="C02LA51" />
<ATC code="C02LA71" />
<ATC code="C02AA52" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="IRREVERSIBLE MONOAMINE OXIDASE INHIBITORS (MAOI)" code="N06AF0" /></DRUG2>
<DESCRIPTION>Psychomotor agitation, convulsions, hypertension</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>451-RESERPINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="RESERPINE" rxcui="9260">
<ATC code="C02AA02" />
<ATC code="C02LA01" />
<ATC code="C02LA51" />
<ATC code="C02LA71" />
<ATC code="C02AA52" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="LEVODOPA" rxcui="6375">
<ATC code="N04BA01" />
<ATC code="N04BA02" />
<ATC code="N04BA03" />
</DRUG>
</DRUG2>
<DESCRIPTION>Inhibition of the effects of the levodopa</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
</INTERACTIONS>
